Table 1 |
|||||||||||||
|
HIV prevalence among antenatal care attendees who tested for HIV, relative risk and χ2 for trend test across the years by sub-city |
|||||||||||||
|
Sub-city |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
χ2 trend |
||||||
|
|
|||||||||||||
|
% (n) |
RR |
% (n) |
RR |
% (n) |
RR |
% (n) |
RR |
% (n) |
RR |
% (n) |
RR |
||
|
|
|||||||||||||
|
Addis Ketema |
12.8(195) |
Ref |
11.1(168) |
0.99 |
7.4(170) |
0.66 |
7.8(231) |
0.70 |
4.6(178) |
0.41 |
4.7(130) |
0.42 |
127.3 * |
|
Akaki Kaliti |
8.7(99) |
Ref |
7.0(131) |
0.81 |
6.8(16) |
0.78 |
4.9(136) |
0.57 |
5.3(113) |
0.61 |
22.3 * |
||
|
Arada |
8.9(134) |
Ref |
8.2(185) |
0.92 |
6.3(159) |
0.71 |
5.9(298) |
0.66 |
3.8(123) |
0.43 |
64.4 * |
||
|
Bole |
8.6(89) |
Ref |
10.0(112) |
1.17 |
6.8(149) |
0.79 |
5.5(158) |
0.64 |
4.8(171) |
0.56 |
3.2(130) |
0.37 |
105.4* |
|
Gulele |
6.7(77) |
Ref |
6.6(118) |
0.98 |
5.7(156) |
0.84 |
5.0(136) |
0.75 |
4.5(93) |
0.67 |
12.1** |
||
|
Kirkos |
10.2(89) |
Ref |
9.5(188) |
0.93 |
7.1(162) |
0.69 |
6.8(191) |
0.66 |
4.6(122) |
0.44 |
54.3 * |
||
|
Kolfe Keraniyo |
5.4(67) |
Ref |
4.9(75) |
0.91 |
2.8(70) |
0.51 |
3.3(73) |
0.62 |
3.7(81) |
0.69 |
7.7‡ |
||
|
Lideta |
9.6(148) |
Ref |
10.2(244) |
1.06 |
6.8(198) |
0.71 |
5.9(228) |
0.62 |
4.8(246) |
0.50 |
4.6(217) |
0.48 |
119.8* |
|
Nifas-silk Lafto |
8.0(175) |
Ref |
7.5(253) |
0.93 |
6.0(232) |
0.74 |
4.6(217) |
0.57 |
4.0(140) |
0.49 |
70.5* |
||
|
Yeka |
7.9(161) |
Ref |
7.6(228) |
0.96 |
8.2(206) |
1.03 |
9.3(268) |
1.17 |
9.2(193) |
1.17 |
6.2‡ |
||
|
|
|||||||||||||
|
Ref = Reference *P < 0.0001 **P < 0,001 ‡P < 0,01 ‡ ‡ P < 0,05 NB: The denominator for each cell is different |
|||||||||||||
|
Mirkuzie et al. BMC Health Services Research 2010 10:267 doi:10.1186/1472-6963-10-267 |
|||||||||||||
